340B PATIENTS Act of 2025

# 340B PATIENTS Act of 2025 - Summary **What the Bill Would Do** The 340B PATIENTS Act of 2025 would modify the federal 340B drug pricing program, which requires pharmaceutical manufacturers to offer significant discounts on medications to certain healthcare facilities and organizations. While the bill's specific provisions aren't detailed in the available information, bills with this title typically aim to protect patient access to discounted drugs or prevent entities from circumventing the program's requirements. This act would affect how hospitals, clinics, and other covered entities can purchase and distribute discounted medications. **Who It Affects** The bill would impact pharmaceutical manufacturers, hospitals, health systems, safety-net providers (like federally qualified health centers), and ultimately patients who depend on these discounted medications.

It may also affect pharmacy benefit managers and other middlemen in the drug distribution process. **Current Status** The bill (HR 4581) was introduced in the 119th Congress by Representative Doris Matsui (D-CA) and is currently in committee, meaning it has not yet been debated or voted on by the full House of Representatives. For specific details about the bill's exact provisions, you can visit Congress.gov.